Tranexamic Acid in Total Hip Arthroplasty.

• Status: Completed
• Trial end date: 2016-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare a single preoperative dose of 1g of tranexamic acid (TXA) versus a preoperative dose of 1g of TXA followed by a continuous infusion of 1g over height hours on blood loss.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier Universitaire de Saint Etienne
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Patient requiring hip arthroplasty in first line, except recent hip fracture (less than 3 months)

• Consent of the patient or a family member or the support person.

Exclusion Criteria:

• Contraindication to tranexamic acid.

• Contraindication to apixaban.

• Pregnancy.

• Patient receiving a curative anticoagulating treatment in the preoperative period.